Posts

Novo Nordisk to Cut 400 Jobs at Bloomington, Indiana Facility Amid Prior Ownership Layoffs

on

Eli Lilly's Orforglipron Obesity Pill Gains FDA Approval, Challenging Novo Nordisk's Wegovy

on

No Recent NICE Cardio Approval for Wegovy

on

Dual-Action Molecule and Drug Combos Show Promise in Treating Multiple Cancers in Mice Models

on

FDA Approves Eli Lilly's Oral GLP-1 Pill Foundayo (Orforglipron) as Response to Novo Nordisk

on

Ambrosia Raises $100M Series B to Develop Next-Generation Small Molecule GLP-1s

on

Ambrosia Biosciences Raises $100M Series B for Oral GLP-1 Drug Development

on

Merck Partners with Infinimmune on $838 Million Antibody Discovery Deal

on

Novo Nordisk Launches Discounted Subscription Program for Wegovy

on

AstraZeneca's Efzimfotase Alfa Fails Phase 3 Trial in Adolescents and Adults with Hypophosphatasia

on

Public Perceptions and Economic Implications of MAHA in 2025 Research

on

Immunic Appoints Jon Congleton to Board of Directors

on

Astellas Announces Top Management Personnel Change: Nick Eshkenazi to Depart as CDTO

on

Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer

on

Baebies FINDER Platform Achieves Dual 510(k) Clearance and CLIA-Waiver for Flu/COVID-19 Test, Breaking PCR-Only Barrier

on

Merck's Keytruda Sets New Standard in Platinum-Resistant Ovarian Cancer with First IO Overall Survival Win

on

Recent Advances in Wet AMD Treatments and Market Insights

on

IO Biotech Files for Chapter 7 Bankruptcy After FDA Refusal on Cancer Vaccine

on

AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway in Skin Diseases

on

Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

on